156 related articles for article (PubMed ID: 33429792)
1. A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas.
Zhao ZL; Liu C; Wang QZ; Zhang WB; Shao L; Wu HW; Zheng JW
Medicine (Baltimore); 2021 Jan; 100(1):e24146. PubMed ID: 33429792
[TBL] [Abstract][Full Text] [Related]
2. A survey on clinical use of propranolol for infantile hemangiomas in mainland China.
Chen ZG; Zheng JW; Zhang L; Zhu L; Wang YA
Int J Clin Exp Med; 2015; 8(2):2138-46. PubMed ID: 25932144
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
4. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of infantile hemangiomas treated with atenolol.
Ballona R; Zevallos J; Núñez J
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423413
[TBL] [Abstract][Full Text] [Related]
6. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
8. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.
Wang Q; Xiang B; Chen S; Ji Y
Australas J Dermatol; 2019 Aug; 60(3):181-185. PubMed ID: 30515761
[TBL] [Abstract][Full Text] [Related]
10. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
12. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
13. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
14. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
15. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
16. Use of propranolol for infantile hemangiomas.
Küpeli S
Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
[TBL] [Abstract][Full Text] [Related]
17. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
Gumina ME; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
19. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
20. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
